Volume : 12, Issue : 06, June – 2025
Title:
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR THE ESTIMATION OF ITRACONAZOLE IN TABLET BY RP-HPLC
Authors :
Mahesh S. Armal*, Pooja S. Gonge, Dr. Dhirendra B. Sanghai, Prof. Dr. Nitin S. Bhajipale
Abstract :
Itraconazole (ITRA) is a broad-spectrum antifungal agent widely used for the treatment of systemic and superficial fungal infections. Due to its poor water solubility and variable bioavailability, a precise and validated analytical method is essential for its accurate quantification in pharmaceutical dosage forms. The present study aimed to develop and validate a simple, accurate, and robust reverse-phase high-performance liquid chromatography (RP-HPLC) method for the estimation of Itraconazole in tablet formulations. The method was developed using an Inertsil C18 column (250 mm × 4.6 mm, 5 μm) with a mobile phase consisting of Acetonitrile: Potassium dihydrogen phosphate buffer (65:35 v/v), pH adjusted to 3.5. The flow rate was maintained at 1 mL/min and detection was carried out at 258 nm. Physicochemical characterization including melting point (167°C), FTIR, and UV analysis (λmax 258 nm) confirmed the identity and purity of the drug. The retention time of Itraconazole was found to be sharp and consistent with good peak symmetry. The method was validated as per ICH Q2(R1) guidelines and was found to be linear (R² = 0.9999) over the concentration range of 10–100 µg/mL. Accuracy, precision, specificity, ruggedness, robustness, and system suitability parameters were all within acceptable limits. The method was successfully applied to the analysis of laboratory mixtures and marketed formulations. This study concludes that the proposed RP-HPLC method is highly suitable for routine quality control analysis of Itraconazole in tablet dosage forms.
KEYWORDS: Itraconazole, RP-HPLC, Method Development, Method Validation, Tablet Formulation, UV Spectroscopy, FTIR, ICH Guidelines, Mobile Phase Optimization, Pharmaceutical Analysis etc.
Cite This Article:
Please cite this article in press Mahesh S. Armal et al., Development And Validation Of Analytical Method For The Estimation Of Itraconazole In Tablet By Rp-Hplc.,Indo Am. J. P. Sci, 2025; 12(07).
Number of Downloads : 10
References:
1. Lloyed R. Snyder, Joseph J. Krikland, Joseph L. Glajch, 2nd ed., John wiley & Sons, INC. 1997 p.1-20
2. ICH guideline, Q2 (R1) step 4, Validation of Analytical Procedures: Text and Methodology (2005)
3. Sahoo, Chinmaya Keshari, et al. “Validation of analytical procedures-A review.” Asian Journal of Pharmaceutical Analysis 8.2 (2018): 109-116.
4. Johan W. Dolan, LCGC North America 24-4(2006) 374.
5. ICH. International Conference on Harmonization (ICH). Guidance for industry: Q1A(R2) Stability testing of new drug substances and products. ICH Harmon Tripart Guidel. 2003; 4(February):24.
6. Rathod N, Prajapati PAI. Analytical Method Development and Validation of Stability Indicating Method and Related Substance by Using RP-HPLC of Drug Substance. J Pharm Anal. 2018; 8(5):367–72.
7. Vyas AJ, Visana NM, Patel AI, Patel AB, Patel NK, Shah SR. Analytical quality by design in stress testing or stability-indicating method. Asian J Pharm Anal. 2021; 11(2):170–8.
8. Patel AB, Asnani AH, Vyas AJ, Patel NK, Patel AI, Lumbhani AN. A Brief Review on Genotoxic impurities in Pharmaceuticals. Asian J Pharm Res. 2021 [cited 2023 Feb 16]; 11(3):187–93
9. B. Patel A, K. Jinja B, Kumar J. Vyas A, K. Patel N, I. Patel A, B. Sheth D, et al. A Retrospective Study of Warning letters Issued by US FDA Over 2019-2021. Asian J Pharm Res. 2022; (483):295–301.
10. Patel AB, Bundheliya AR, Vyas AJ, Patel NK, Patel AI, Lumbhani AN. A review on metal impurities in pharmaceuticals. Asian J Pharm Anal. 2021; 11(3):212–22.
11. Ajay I. Patel, Krupa B.Prajapati, Amit J. Vyas, Ashok B. Patel, Nilesh K. Patel. Determination and validation of phthalate impurities in milk by uv-spectrophotometry method. Monitor PS. 2019; 10(4):49–58
12. Rajput M, Patel N, Chotaliya U, Patel A, Patel A, Vyas A. Determination of genotoxic impurity by chromatographic method. Pharma Sci Monit. 2017; 8(2):24–31.
13. Vyas AJ, Patel SM, Patel AB, Patel AI, Patel NK, Shah S, et al. Stability testing: An Essential study for Vaccine Formulation Development. Asian J Pharm Res. 2022; 12(1):29–36.
14. Vyas AJ, Gol DA, Patel AI, Patel AB, Patel NK, Chavda JR, et al. Implementing analytical quality by design (AQbD) approach for simultaneous estimation of tadalafil and macitentan by RP-HPLC asian. Anal Chem Lett. 2021; 11(4):539–52.
15. Patel AI, Prajapati KB, Jolapara SH, Vyas AJ, Patel AB, Patel NK, et al. RP-HPLC method for determination of Gemfibrozil using central composite design (CCD). Res J Pharm Technol. 2021; 14(6):3009–14.
16. Shinde NG, Bangar BN, Deshmukh SM, Sulake SP, Sherekar DP. Pharmaceutical Forced Degradation Studies with Regulatory Consideration. Asian J Res Pharm Sci. 2013; 3(4):178–88.
17. Singh Chauhan Y, Nex R, Sevak G, Singh Rathore M. Stability Testing of Pharmaceutical Products. Res J Pharm Dos Forms Technol. 2021; 13(04):317–28.
18. Roge AB, Tarte PS, Kumare MM, Shendarkar GR, Vadvalkar SM. Forced Degradation Study: An Important Tool in Drug Development. Pharm Res. 2013; 3(January):99–102.
19. Sutar S V., Yeligar VC, Patil SS. A review: Stability indicating forced degradation studies. Res J Pharm Technol. 2019; 12(2):885–90.
20. Sherawat R, Maithani M, Singh R, Regulatory aspects in development of stability indicating method: A review. Chromatographia 2010; 72:1-6
21. Analytical procedures and methods validation for drugs and biologics guidance for industry. Fda.gov. 2015
22. Szepesi G, Gazdag M, Mihályfi K. Selection of high-performance liquid chromatographic methods in pharmaceutical analysis. III. Method validation. J Chromatogr. 1989; 464(2):265–78.
23. Carr GP, Wahlich JC. A practical approach to method validation in pharmaceutical analysis. J Pharm Biomed Anal. 1990; 8(8–12):613–8.
24. Jenke DR. Chromatographic method validation: A review of current practices and procedures. I. general concepts and guidelines. J Liq Chromatogr Relat Technol. 1996; 19(5):719–36.
25. Shanthi Priya DK, Mukthinuthalapati Mathrusri Annapurna. Stability indicating RP- HPLC method for the simultaneous estimation of Olaparib & Bevacizumab in pharmaceutical dosage forms. Research Journal of Pharmacy and Technology. 2024; 17(2):910-4. doi: 10.52711/0974-360X.2024.00141
26. Amitkumar J. Vyas, Chirag D. Jadav, Ajay I. Patel, Ashok B. Patel, Sunny R. Shah, Devang Sheth, Sandip Dholakia. Review on Stability Indicating Assay Method or Forced Degradation Study: Strategy and Regulatory Consideration. Asian Journal of Pharmaceutical Analysis. 2023; 13(2):131-9. doi: 10.52711/2231-5675.2023.00022
27. Velagacherla V, Nayak Y, Bhaskar KV, et al.: Validation of RP-HPLC for Nintedanib.Dataset. figshare. 2023. 10.6084/m9.figshare. 23565852.v1
28. Kamlesh Kashinath Saindane , Harshada Talapadatur , Vijay Kumar Munipalli , Raman Mohan Singh , Bharti Fegade , Vaidun Bhaskar Stability Indicating RP-HPLC Method for the Estimation of Selumetinib in Capsule Dosage Form. Int. J. Pharm. Sci. Rev. Res., 74(2), May – June 2022; Article No. 26, Pages: 166-174
29. Samineni R, chimakarthy J, yamarthy V. Development and validation of analytical method for estimation of balofloxacin in bulk and pharmaceutical dosage form by RP – HPLC Research Journal pharmacy and Technology 2022;15(7):2992-2996.
30. Baile M, Ramole R, and Jain A. a Review: Analytical Method development and validation 2021;12(8):450-454.
31. Singh B, Lakew A. a research article on development and validation of HPLC method for simultaneous determination multiclass seven antibiotic residues in chicken tissue, 2022;5:1335.
32. Almalki A, Hussein E. a research article on development and validation of ecofriendly HPLC-MS method for quantitative assay of amoxicillin, dicloxacillin, and their official impurity in pure and dosage form J Anal Chem, 2021;2:40-76.
33. Caro S. a research of bioanalytical methods for the therapeutic drug monitoring of beta lactum antibiotics in critically ill patients World J Pharm Res, 2020;210:405-426.
34. International Conference on Harmonization. Q3B (R2): Impurities in New Drug Products. London, UK: European Medicines Agency; 2003; 68(220):64628–64629
35. FDA, Guidelines for Submitting Documentation for Stability of Human Drugs and Biologics Food and Drug Administration, Rockville 1998.
36. Guidance for Industry: Submitting Documentation for the Stability of Human Drugs and Biologics Food and Drug Administration, Rockville, 1987.
37. Guidance for Industry (Draft): Stability Testing of Drug Substances and Drug products Food and Drug Administration, Rockville, 1998.
38. Michael Kats. Forced Degradation Studies: Regulatory Considerations and Implementation. BioPharm International, 2005: 1-08
39. Hovorka S, Schöneich C. Oxidative degradation of pharmaceuticals: theory, mechanisms and inhibition. J Pharm Sci. 2001; 90(3):253–69.
40. Anderson NH, Johnston D, McLelland MA, Munden P. Photostability testing of drug substances and drug products in UK pharmaceutical laboratories. J Pharm Biomed Anal. 1991; 9(6):443–9.
41. Bakshi M, Singh S., Development of Validated StabilityIndicating Assay Methods: Critical Review. J. Pharm. Biomed. Anal. 28; 2002: 1011–1040
42. Singh S, Bakshi M. Guidance on conduct of stress tests to determine inherent stability of drugs. Phrama Tech 24, 2000: 1- 14.
43. Skoog, DA, West DM. Principles of Instrumental Analysis. Saunderg Golden, Japan. 1980: 2-3.
44. Brummer H., How to approach a forced degradation study. Life science technical bulletin issue. 2011: 3.
45. Satyajit, D. Sarker., and Lutfun Nahar., Hyphenated Techniques, Natural Products Isolation, The series Methods in Biotechnology, 20, 233-267, (2005).
46. Pallavi Phalke., and Shilpa Kavade., Review on Hyphenated Techniques, Int. J. Chem. Stud, 1(3), 157, (2013).
47. Chromatography – The most versatile method of chemical analysis, Edited by Leonardo de Azevedo calderon, ISBN-978 – 953- 51- 08913 – 9, Publisher – InTech.
48. http://www.laboratoryequipment.com/article/2012/12/analytical-instruments-drive- pharmaceutical-r-d
49. Tswett, M. S., Proc. Warsaw Natural Biol. Soc., 14, 20, (1903).
50. Tswett, M. S., Chromophils in Animal and Plant World, Doctor of Science dissertation, Warsaw, 379, (1910).
51. Palmer, L. S., Carotenoids and Related Pigments, The Chromophlipids, ACS Monograph Series, American Chemical Society, New York, 316, (1922).
52. Snyder, L. R., Kirkland, J. J., and Dolan, J. W., Introduction to Modern Liquid Chromatography, Third edition, New Jersey, USA, John Wiley & Sons, Inc., (2010).
53. Snyder, L. R., Kirkland, J. J., and Glajch, J. L., Practical HPLC Method Development, Second Edition, New York, USA, John Wiley & Sons, Inc., (1997).
54. Vijaykumar T. Pawar, Harinath N. More, Manish S. Bhatia Development and Validation Of RP-HPLC Method For The Determination Of Lisinopril And Amlodipine In Bulk And Multicomponent Pharmaceutical Cardiovascular Dosage Form Nat. Volatiles & Essent. Oils, 2021; 8(4): 9441-9451
55. Jat S, Singh G. Development and Validation of A HPLC Analytical Assay Method for Amlodipine Besylate Tablet. International journal of pharmacy and pharmaceutical research. Human, 2020; 17(4): 687-695.
56. Dhanera M, Chaturvedi P, Tiwari A. analytical method validation of rp-hplc for the estimation of atenolol and amlodipine besylate in bulk and tablet dosage forms. International Journal of Pharmaceutical Sciences and Medicine, 2020; .5 (10): 1-18
57. Mohammed El mowafy Quality by design (QbD) based development and validation of bioanalytical RP-HPLC method for dapagliflozin: Forced degradation preclinical pharmacokinetic study Journal of Liquid Chromatography & Related Technologies 43 (12), 53-65, 2020.
58. Krier F, Brion M, Debrus B, Lebrun P, Driesen A, Ziemons E et al. Optimization and validation of a fast HPLC method for the quantification of sulindac and its related impurities. J Pharm Biomed Anal. 2011;54(4):694-700.
59. Zecević M, Zivanović L, Agatonovic-Kustrin S, Minic D. The use of a response surface methodology on HPLC analysis of methyldopa, amiloride and hydrochlorothiazide in tablets. J Pharm Biomed Anal. 2001;24(5-6):1019-25.
60. Şanli S, Palabiyik İM, Şanli N, Guzel-Seydim ZB, Alsancak G. Optimization of the experimental conditions for macrolide antibiotics in high performance liquid chromatography by using response surface methodology and determination of Tylosin in milk samples. J Anal Chem. 2011;66(9):838-47.
61. Schmidt AH, Molnár I. Using an innovative Quality-by-Design approach for development of a stability indicating UHPLC method for ebastine in the API and pharmaceutical formulations. J Pharm Biomed Anal. 2013;78-79:65-74.
62. Saurabh b Ganorkar, Atul A Shirkhedkar,Design of Experiments in HPLC analysis, application implication and future prospectus Review in Analytical Chemistry Doi.org/10.1515/revac-2016-0025
63. Zec M, Zivanović L, Agatonovic-Kustrin S, Minic D. The use of a response surface methodology on HPLC analysis of methyldopa, amiloride and hydrochlorothiazide in tablets. J Pharm Biomed Anal. 2001;24(5-6):1019-25.
64. Nistor I, Lebrun P, Ceccato A, Lecomte F, Slama I, Oprean R et al. Implementation of a design space approach for enantiomeric separations in polar organic solvent chromatography. J Pharm Biomed Anal. 2013; 74:273-83.
65. Smajic M, Vujić Z, Mulavdic N, Brborić J. An improved HPLC method for simultaneous analysis of losartan potassium and hydrochlorothiazide with the aid of a chemometric protocol. Chromatographia. 2013;76(7-8):419-25.
66. Petkovska R, Dimitrovska A. Use of chemometrics for development and validation of an RP-HPLC method for simultaneous determination of haloperidol and related compounds. Acta Pharm. 2008;58(3):243-56
67. Bezerra MA, Santelli RE, Oliveira EP, Villar LS, Escaleira LA. Response surface methodology (RSM) as a tool for optimization in analytical chemistry. Talanta. 2008;76(5):965-77.
68. ICH Q8 (R2). Pharmaceutical Development. Step 4 version Nov 2009. ICH. p. 01-24.
69. Al-Badr, Abdullah A., and Hussein El-Subbagh. “Itraconazole: comprehensive profile.” Profiles of drug substances, excipients and related methodology. Vol. 34. Academic Press, 2009. 193-264.
70. De Beule, Karel, and Jef Van Gestel. “Pharmacology of itraconazole.” Drugs 61.Suppl 1 (2001): 27-37.
71. Cauwenbergh G., et al. “Pharmacokinetic profile of orally administered itraconazole in human skin.” Journal of the American Academy of Dermatology 18.2 (1988): 263-268.